Results 141 to 150 of about 14,264 (186)

Glucocorticoid-Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most. [PDF]

Diabetes Obes Metab
Burt MG, Khalili F, Radhakutty A, Chen AX.   +3 more
europepmc   +1 more source

Continuous Glucose Monitoring-Informed Basal Insulin Optimization System in Adults with Type 2 Diabetes: Initial Evaluation of Efficacy, Safety, and Impact on Patient-Reported Outcomes. [PDF]

Diabetes Ther
Oser SM, Crystal C, Hames KC, Li X, Gao P, Crawford MA, Hicks C, Gerber M, Gautier T, Colmegna P, Yang L, Singh H, Johnson ML, Beck SE.   +13 more
europepmc   +1 more source

Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes. [PDF]

BMC Endocr Disord
Altun I, Güneş Kaya D, Uçar M, Gözderesi Y, Haşlak GV, Karakaş H, Bayramoğlu E, Evliyaoglu O, Turan H.   +8 more
europepmc   +1 more source

Case Report: Case analysis of a juvenile type 1 diabetes mellitus patient with Mauriac syndrome. [PDF]

Front Endocrinol (Lausanne)
Fu R, Yang M, Guo Y, Huang Y, Li X, Zhang M.   +5 more
europepmc   +1 more source

Cost-utility of once-weekly insulin icodec versus once-daily basal insulins for type 2 diabetes in China. [PDF]

Diabetes Obes Metab
Tong X, Xing C, Zhang L, Zhang L.
europepmc   +1 more source

Early insulin initiation in type 2 diabetes: efficacy, safety, and clinical implications: a systematic review with narrative synthesis. [PDF]

Front Endocrinol (Lausanne)
Albasheer O, Mohamed AH, Abdalghani N, Hamdi A, Ayish DAM, Ayish F, Alssum A, Maashi AY, El Hassan LAM, Madkhali T, Muqri M, Awaf AA, Alessa H, Madkhali A, Hakami A.   +14 more
europepmc   +1 more source

Dulaglutide Effect on Proteins Associated With CKD Progression. [PDF]

Kidney Int Rep
McFarlin BE, Tye SC, Satake E, Md Dom ZI, Kechter A, Wilson JM, Krolewski AS, Duffin KL.   +7 more
europepmc   +1 more source

Successful rapid desensitization to multiple insulin preparations in an adult with type 1 diabetes: a case report and literature review. [PDF]

Front Endocrinol (Lausanne)
Chen Y, Zhu W, Chen G, Yao J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Insulin glargine

The Lancet, 2000
Insulin glargine is an extended-action biosynthetic human insulin. It precipitates in the neutral environment of subcutaneous tissue and is thus gradually absorbed into the bloodstream. The addition of small amounts of zinc to the formulation further delays absorption.
G B, Bolli, D R, Owens
  +9 more sources